期刊文献+

健脾抑瘤汤对晚期原发性肝癌患者免疫功能的影响

Is good for the spleen damps the lump soup to the later period primary liver cancer patient immunity function influence
原文传递
导出
摘要 目的:观察健脾抑瘤汤对晚期原发性肝癌患者免疫功能的影响.方法:将60例患者随机分成治疗组与对照组各30例,两组患者均采用相同的西医药疗法治疗.治疗组同时加用健脾抑瘤汤治疗,两组30天为1疗程,一个疗程评价疗效.观察两组治疗前后生活质量及免疫功能变化情况.结果:两组生活质量(卡氏评分)变化比较,治疗组与对照组提高稳定率分别为80.0%、56.7%(P〈0.05);两组治疗前后T淋巴细胞亚群变化比较,治疗后两组CD3、CD4、CD4/CD8均有不同程序的升高,与治疗前比较差异均有显著性(P〈0.01或P〈0.05),且治疗组明显高于对照组(P〈0.05).结论:健脾抑瘤汤具有提高机体免疫功能,改善临床症状及生活质量,延长生存期. Objective:The observation is good for the spleen damps the lump soup to the later period primary liver cancer patient immunity function influence. Methods:Divides into the treatment group and control group each 30 examples stochastically 60 example patients, two group of patients use the same doctor practicing western medicine pharmacotherapy treatment. The treatment group simultaneously adds with is good for the spleen damps the lump soup treatment,two groups 30 days are 1 treatment course,a treatment course appraisal curative effect. Around observes two groups to treat the quality of life and the immunity function change situation. Results:Two group of qualities of life (card grades) changes the comparison, the treatment group and the control group enhances the index of stability respectively is 80.0 %, 56.7% (P〈0.05) ;Around two groups treat the T lymphocyte subgroup change comparison,treats latter two group of CD 3, CD 4, CD 4/CD 8 has the different procedure ascension, the comparison difference has the significance with the treatment before (P〈0.01 or P〈0, 05), also the treatment group is higher than the control group obviously (P〈0.05). Conclusion:Is good for the spleen damps the lump soup to have enhances organism immunity function, the improvement clinical symptom and the quality of life,the extension lifetime.
作者 陈强松
出处 《按摩与康复医学》 2011年第9期62-63,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 晚期原发性肝癌 健脾抑瘤汤 免疫功能 Later period primary liver cancer is good for the spleen damps the lump soup Immunity function
  • 相关文献

参考文献5

二级参考文献17

  • 1武文森,尹克铮,韩月明,张晓明,张东生,洪大落.小鼠可移植性膀胱移行细胞癌株(BTT739)的建立及实验研究[J].中国肿瘤临床,1996,23(10):751-756. 被引量:23
  • 2Yu GQ, Liang FY, Zhang DZ. Integrated traditional Chinese and western medicine in preventing and treating malignant tumor towards the 21st century. Chin J Integr Tradit West Med (English edition) 1999;5(1):2-5.
  • 3Morita S, Ohashi Y, Hirakawa K, et al. Phase Ⅰ/Ⅱ study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy. Jpn J Clin Oncol 2004;34(3):159-161.
  • 4Shiina S,Teratani T,Obi S,et al.Nonsurgical treatment of hepatocellular carcinoma:percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.Oncology,2002,62(s1):64-68
  • 5Livraghi T,Goldberg SN,Lazzaroni S,et al.Small hepatocellular carcinoma:treatment with radiofrequency ablation versus ethanol injection.Radiology,1999,210(3):655-661
  • 6Lau WY,Leung TW,Yu SC,et al.Percutaneous local ablative therapy for hepatocellular carcinoma:a review and look into the future.Ann Surg, 2003,237(2):171-179
  • 7Di CV,Ferrari G,Castoldi R,et al.Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology,1998,45(24):1950-1954
  • 8Camma C,Schepis F,Orlando A,et al.Transarterial chemoembolization for unresectable hepatocellular carcinoma:meta-analysis of randomized controlled trials.Radiology, 2002,224(1):47-54
  • 9Michael W. Graner,Yi Zeng,Hanping Feng,Emmanuel Katsanis.Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers[J].Cancer Immunology Immunotherapy.2003(4)
  • 10M. G. Mack,R. Straub,K. Eichler,K. Engelmann,A. Roggan,D. Woitaschek,M. B?ttger,T. J. Vogl.Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases[J].Abdominal Imaging.2001(4)

共引文献260

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部